Exploring Factors behind Patient Nonadherence to Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Macular Diseases
Study results highlight modifiable factors contributing to no-shows to anti-VEGF IVT, such as poor transportation access, complicated administrative processes, and difficulty rescheduling missed appointments. Understanding potential obstacles to anti-VEGF IVT therapy, particularly those that are preventable, can enhance adherence and potentially improve the clinical outcome.
Authors
- Arnold Fishman
- Nitai Bar (ORCID: https://orcid.org/0000-0002-7997-0354)
- Shiri Zayit‐Soudry (ORCID: https://orcid.org/0000-0002-8736-1823)
- Efrat Naaman
- Diana Shair
- B. H. Miller
- Noa Yanir-Prat
Institutions
- Technion – Israel Institute of Technology (IL)
- Rabin Medical Center (IL)
- Rambam Health Care Campus (IL)
Publication Details
- Journal
- Ophthalmic Research
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1159/000543352
- Citations
- 3
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.12